ARCHIVES

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

With workload Up, Oncology Division To Add More Staff

August 2, 1996

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals

March 28, 1997

FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke.

March 18, 2005

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992